Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_assertion type Assertion NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_head.
- NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_assertion wasGeneratedBy ECO_0000203 NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_provenance.
- NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_assertion wasDerivedFrom befree-2016 NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_provenance.
- NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_assertion SIO_000772 16319097 NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_provenance.
- NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_assertion evidence source_evidence_literature NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_provenance.
- NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_assertion description "[VIP treatment decreased CCL2 and CXCL8 chemokine production in response to TLR4 activation with LPS in RA FLS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524536.RA1FCWrn_1lUACAFTw5Exw-E1mOV3VueklvUMw5nEqf1Y130_provenance.